Shopping Cart
Remove All
Your shopping cart is currently empty
Letolizumab
😃Good
Catalog No. T77061Cas No. 1450981-87-9
Alias BMS-986004, BMS986004, BMS2h-572-633-CT-L2
Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.1 Letolizumab does not induce platelet activation in vitro and does not affect coagulation factors or platelet counts/function after repeated dosing in non-human primates.
Letolizumab
Letolizumab
😃Good
Catalog No. T77061Alias BMS-986004, BMS986004, BMS2h-572-633-CT-L2Cas No. 1450981-87-9
Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.1 Letolizumab does not induce platelet activation in vitro and does not affect coagulation factors or platelet counts/function after repeated dosing in non-human primates.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $169 | In Stock | In Stock | |
| 5 mg | $448 | In Stock | In Stock | |
| 10 mg | $715 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,460 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:98.8% (SDS-PAGE); 99.2% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.1 Letolizumab does not induce platelet activation in vitro and does not affect coagulation factors or platelet counts/function after repeated dosing in non-human primates. |
| Targets&IC50 | CHO-CD40L (human):1.3 nM, CHO-CD40L (non-human primate):7.3 nM, CD40L trimer (non-human primate):3.8 nM, CD40L trimer (human):3.6 nM |
| In vitro | Letolizumab inhibited the viability of CD40L trimer and CHO-CD40L in human B-cells and in non-human primate B-cells with IC50 values of 3.6 nM and 1.3 nM, and 3.8 nM and 7.3 nM, respectively. [2] |
| In vivo | Letolizumab treatment at doses of 2, 10, and 20 mg/kg administered intravenously once a week for 10 weeks significantly prolonged the survival time of rhesus monkeys after kidney transplantation. [2] |
| Synonyms | BMS-986004, BMS986004, BMS2h-572-633-CT-L2 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TNFSF5/CD40L/CD154 |
| Molecular Weight | 38.99 kDa |
| Cas No. | 1450981-87-9 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG1-AST-4xS |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Letolizumab | purchase Letolizumab | Letolizumab cost | order Letolizumab | Letolizumab in vivo | Letolizumab in vitro | Letolizumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.